SUNNYVALE, Calif., Jan. 6, 2021 /PRNewswire/ -- Accuray
Incorporated (Nasdaq: ARAY) today announced its participation in
the 39th J.P. Morgan Annual Healthcare Conference.
Josh Levine, President and CEO, is
scheduled to present on Thursday, January
14, 2021 at 11:00 am PACIFIC /
2:00 pm EASTERN.
The presentation to be delivered at the J.P. Morgan Healthcare
Conference can be accessed on the Accuray website at
www.accuray.com/investors following the conclusion of Mr.
Levine's talk.
To arrange one-on-one virtual meetings with Accuray senior
management during the conference, institutional investors can
contact their J.P. Morgan representative or email Joe Diaz with Accuray Investor Relations at
jdiaz@accuray.com.
About Accuray
Accuray is committed to expanding the powerful potential of
radiation therapy to improve as many lives as possible. We invent
unique, market-changing solutions to deliver radiation treatments
for even the most complex cases—while making commonly treatable
cases even easier—to meet the full spectrum of patient needs. We
are dedicated to continuous innovation in radiation therapy for
oncology, neuro-radiosurgery, and beyond, as we partner with
clinicians and administrators, empowering them to help patients get
back to their lives, faster. Accuray is headquartered in
Sunnyvale, California, with
facilities worldwide. To learn more, visit www.accuray.com or
follow us on Facebook, LinkedIn, Twitter, and YouTube.
Investor Contacts
Lytham Partners
Joe Diaz
+1 (602) 889-9700
jdiaz@accuray.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/accuray-to-participate-at-jp-morgans-39th-annual-healthcare-conference-301201611.html
SOURCE Accuray Incorporated